Sleep apnoea—a condition where the airway becomes blocked during sleep, leading to interrupted breathing is a prevalent disorder affecting millions worldwide. While Continuous Positive Airway Pressure (CPAP) therapy has been the standard for treatment in patients with severe sleep apnoea, it doesn’t work for everyone. Recent research from Flinders University is challenging traditional approaches, offering promising alternatives.
A Shift in Treatment Paradigm
Professor Danny Eckert, Director of the Adelaide Institute for Sleep Health at Flinders University, has been at the forefront of rethinking sleep apnoea treatment. His team’s research highlights that a significant number of patients do not respond well to CPAP therapy. Instead of relying solely on CPAP, their studies suggest that combining therapies tailored to individual patient needs can yield better outcomes.
In a groundbreaking study published in the Annals of the American Thoracic Society, researchers explored a “stepwise add-on” approach. This method involves starting with less invasive treatments and progressively adding therapies based on the patient’s response. The results were promising, with many participants achieving effective treatment without the need for CPAP. Only a few cases required CPAP as a last resort, indicating that this new model could revolutionise sleep apnoea management.
Personalised Therapy: The Role of Endotype-Informed Treatment
A key aspect of this new approach is the concept of “endotype-informed” therapy. Endotypes refer to distinct subtypes of a condition, each with unique underlying mechanisms. By identifying these subtypes, clinicians can tailor treatments more precisely. In the context of sleep apnoea, this means understanding the specific factors contributing to airway obstruction in each patient and selecting therapies that target those factors directly.
Innovations in Appliance Effectiveness
Beyond pharmacological interventions, non-invasive devices play a crucial role in managing sleep apnoea. Professor Eckert’s team has also focused on enhancing the effectiveness of these devices. One notable development is the improvement of mandibular advancement splints (MAS), which are oral appliances designed to reposition the lower jaw and keep the airway open during sleep. While MAS has been effective for many, some users still experience residual sleep apnoea. To address this, researchers have combined MAS with other targeted therapies based on individual patient profiles, leading to better outcomes.
Looking Ahead
The research emerging from Flinders University underscores a pivotal shift in sleep apnoea treatment—from a one-size-fits-all approach to personalised, patient-centered care. By integrating combination therapies and tailoring treatments to individual endotypes, there’s potential to significantly improve patient outcomes and quality of life. As these innovations continue to evolve, they offer hope for more effective and accessible treatments for those affected by sleep apnoea.
For more detailed information on these studies and their implications, you can read the full article on Flinders University’s website: https://news.flinders.edu.au/blog/2023/08/08/flipping-the-model-presents-a-new-way-to-treat-sleep-apnoea/
SleepWise Clinic is Australia’s market leader in mandibular advancement splint (MAS) therapy, helping thousands of patients manage obstructive sleep apnoea with precision and care.
If you’re looking for a proven, non-invasive alternative to CPAP, or want to explore how combination therapy could work for you, our expert team is here to help.
Book your consultation with SleepWise Clinic and experience why we’re the trusted name in MAS treatment, click the button below.
